Zacks Investment Research
21 Sept 2026, 22:46 UTC · 2h ago
Verdict
Headline leans bearish. We score CVS −0.20 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.20slightly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
CVS Health is forecasted to report a quarterly EPS of $1.6 and revenue of $105.04 billion.
Priced inanalysis of consensus estimates
So whatFlat YoY EPS growth suggests a stagnation in profitability heading into the next print.
More positive than 50% of claims this week
The Zacks Consensus EPS estimate for CVS Health has decreased by 0.03% over the last 30 days.
Continue reading
5 related stories
More negative than 72% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Priced inanalysis of 30-day estimate trend
So whatWhile the move is marginal, negative revision momentum historically correlates with near-term share price weakness.
More negative than 66% of claims this week
CVS Health is trading at a Forward P/E ratio of 11.07, compared to an industry average of 17.31.
Priced inanalysis of current valuation metrics
So whatThe stock trades at a ~36% discount to its peers, potentially limiting downside risk.
More positive than 41% of claims this week
Which stocks this story touches
More negative than 72% of ticker scores this week
The stock price declined recently and is trailing the S&P 500 and its sector.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
CVS hasn't traded since this ran. Last close $87.60 (Sep 21); the reaction starts at the next open.
CVS chart →